The United States Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades Earnings FDA Hot Comments Hot Downgrades Hot FDA News Hot List

Oppenheimer Reiterates Perform Rating on Sage Therapeutics (SAGE)August 7, 2023 4:56 PM SAGE Therapeutics (SAGE) sinks nearly 50% as trading resumes following CRLAugust 7, 2023 7:12 AM